Cannabinoid Pharmacology & Therapeutics Video
Wednesday Nite @ The Lab on PBS features cannabis!
Cannabinoid Pharmacology & Therapeutics
Dr. Natalie Schmitz speaks about the roles and risks of cannabinoid therapies.
Natalie Schmitz of the School of Pharmacy will wrangle with these and other perplexities in her talk entitled “Deep Into the Weeds: Cannabinoid Pharmacology, Therapeutics & Risk.” Here’s how she describes her talk: Cannabinoid use has increased following changes in State and Federal policy. Cannabinoids are thought to treat a myriad of diseases and symptoms, and are available in many different routes of administration including inhalation, oral, sublingual, and topical. We will discuss cannabinoids, how they work, evidence behind their use, and possible risks. About the Speaker: Natalie Schmitz, MPA, PharmD, PhD is an Assistant Professor in the Pharmacy Practice Division at University of Wisconsin’s School of Pharmacy. Prior to joining University of Wisconsin, Dr. Schmitz earned her Master of Public Administration and PharmD at Drake University and then pursued her PhD in Experimental and Clinical Pharmacology at University of Minnesota while working as a Medical Cannabis Pharmacist. Dr. Schmitz’s translational research program focuses on optimizing therapies, particularly cannabinoids, for neurologic conditions by investigating pharmacokinetics, pharmacodynamics, exposure-response, safety and efficacy. Links: The National Academies of Sciences, Engineering, Medicine. The Health Effects of Cannabis and Cannabinoids: The Current State of Evidence and Recommendations for Research.
